Evidence map›Paper›PMID 24412674›Full record

ArticleNeuropharmacology2014

Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.

Brian O'Neill, Michael R Tilley, Dawn D Han, Keerthi Thirtamara-Rajamani, Erik R Hill, Georgia A Bishop, Fu-Ming Zhou, Matthew J During, Howard H Gu

Abstract read
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Dopamine and addiction: what have we learned from 40 years of research.Journal of neural transmission (Vienna, Austria : 1996) · 2019
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Brian O'NeillDepartment of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5184B Graves Hall, Columbus, OH 43210, USA; Neuroscience Graduate Studies Program, The Ohio State University, Columbus, OH 43210, USA.
Michael R TilleyDepartment of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5184B Graves Hall, Columbus, OH 43210, USA.
Dawn D HanDepartment of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5184B Graves Hall, Columbus, OH 43210, USA.
Keerthi Thirtamara-RajamaniDepartment of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5184B Graves Hall, Columbus, OH 43210, USA; Neuroscience Graduate Studies Program, The Ohio State University, Columbus, OH 43210, USA.
Erik R HillDepartment of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5184B Graves Hall, Columbus, OH 43210, USA; Ohio State Biochemistry Graduate Program, The Ohio State University, Columbus, OH 43210, USA.
Georgia A BishopDepartment of Neuroscience, The Ohio State University, Columbus, OH 43210, USA.
Fu-Ming ZhouDepartment of Pharmacology, The University of Tennessee, Memphis, TN 38163, USA.
Matthew J DuringMolecular Virology, Immunology & Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.
Howard H GuDepartment of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5184B Graves Hall, Columbus, OH 43210, USA. Electronic address: gu.37@osu.edu.
The Ohio State University · USUniversity of Tennessee Health Science Center · US

Funding

Mechanism of drug addictionR01DA014610 · NIDA · YALE UNIVERSITY · PI GU, HOWARD H · 2002 to 2013
$3.1M
Cocaine and monoamine transportersR01DA020124 · NIDA · OHIO STATE UNIVERSITY · PI GU, HOWARD H · 2006 to 2009
$1.3M
Cocaine Degrading Enzymes From Pest Insects Of Coca PlantsR21DA025309 · NIDA · OHIO STATE UNIVERSITY · PI GU, HOWARD H · 2009 to 2010
$413k
Harnessing Somatic Hypermutation for Drug Addiction ResearchR21DA025157 · NIDA · OHIO STATE UNIVERSITY · PI GU, HOWARD H · 2008 to 2009
$300k
NIDA NIH HHS DA014610NIDA NIH HHS DA20124NIDA NIH HHS R01 DA014610NIDA NIH HHS R01 DA020124NIDA NIH HHS R21 DA025157NIDA NIH HHS R21 DA025309
6 · The paper itself

Abstract

Cocaine's main pharmacological actions are the inhibition of the dopamine, serotonin, and norepinephrine transporters. Its main behavioral effects are reward and locomotor stimulation, potentially leading to addiction. Using knock-in mice with a cocaine-insensitive dopamine transporter (DAT-CI mice) we have shown previously that inhibition of the dopamine transporter (DAT) is necessary for both of these behaviors. In this study, we sought to determine brain regions in which DAT inhibition by cocaine stimulates locomotor activity and/or produces reward. We used adeno-associated viral vectors to re-introduce the cocaine-sensitive wild-type DAT in specific brain regions of DAT-CI mice, which otherwise only express a cocaine-insensitive DAT globally. Viral-mediated expression of wild-type DAT in the rostrolateral striatum restored cocaine-induced locomotor stimulation and sensitization in DAT-CI mice. In contrast, the expression of wild-type DAT in the dorsal striatum, or in the medial nucleus accumbens, did not restore cocaine-induced locomotor stimulation. These data help to determine cocaine's molecular actions and anatomical loci that cause hyperlocomotion. Interestingly, cocaine did not produce significant reward - as measured by conditioned place-preference - in any of the three cohorts of DAT-CI mice with the virus injections. Therefore, the locus or loci underlying cocaine-induced reward remain underdetermined. It is possible that multiple dopamine-related brain regions are involved in producing the robust rewarding effect of cocaine.

Indexed as

AnimalsCocaineCocaine-Related DisordersConditioning, ClassicalCorpus StriatumDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsGene Knock-In TechniquesHEK293 CellsHumansMiceMice, TransgenicNucleus AccumbensPsychomotor AgitationRewardCocaineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsAddictionCocaineDopamineLocomotionRewardTransporter

Identifiers

PMID24412674
PMCPMC4011184
OpenAlexW2132455548

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.